Arena Pharmaceuticals, Inc. (ARNA)

65.91 +0.52 (+0.80%) As of 9:45AM EST. Market open.

Arena Pharmaceuticals, Inc.

6154 Nancy Ridge Drive
San Diego, CA 92121
United States
858 453 7200
http://www.arenapharm.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 320

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Amit D. Munshi M.B.A.	Pres, CEO & Director	1.23M	N/A	1968
Mr. Vincent E. Aurentz	Exec. VP & Chief Bus. Officer	701.81k	1.66M	1968
Dr. Preston S. Klassen	Advisor	791.36k	512.14k	1969
Mr. Robert Lisicki	Exec. VP & Chief Commercial Officer	841.77k	N/A	1967
Ms. Laurie D. Stelzer	Exec. VP & CFO	N/A	N/A	1968
Dr. Douglas A. Bakan	Exec. VP of Technical Operations	N/A	N/A	N/A
Megan E. Knight	Director of Investor Relations	N/A	N/A	N/A
Ms. Joan Schmidt	Exec. VP, Gen. Counsel & Sec.	N/A	N/A	1964
Ms. Suzanne C. Zoumaras	Exec. VP & Chief HR Officer	N/A	N/A	1964
Mr. Steven W. Spector	Consultant	N/A	N/A	1965

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, a Phase IIb/III clinical trial for Crohn's disease, and a Phase IIb clinical trial for atopic dermatitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; and APD418 that is in Phase I clinical trial for acute heart failure. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; and Eisai Co., Ltd. and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Corporate Governance

Arena Pharmaceuticals, Inc.’s ISS Governance QualityScore as of November 1, 2019 is 4. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.